Intuitive Surgical, Inc.

NASDAQ Global Select
Back to all articles
Bullish +72

Intuitive Announces Second Quarter Earnings - The Manila Times

📈 Second quarter 2026 revenue surged to $2.89 billion, marking a 19% increase from the same period in 2025.

🔬 Instruments and accessories revenue grew by 18% to $1.73 billion, driven by higher procedure volumes across both da Vinci and Ion systems.

🤖 Systems revenue reached $685 million, reflecting increased placements of 468 da Vinci surgical systems compared to 395 in the prior year.

💰 GAAP income from operations expanded to $972 million, while non-GAAP income from operations rose to $1.22 billion.

📉 Net income attributable to Intuitive Surgical hit $818 million, translating to $2.29 per diluted share versus $1.81 in the previous year.

💵 The company ended the quarter with $8.63 billion in cash and investments, up $650 million from the start of the period.

🚀 Ion procedure volume experienced a significant 36% growth rate compared to the second quarter of 2025.

📊 da Vinci system placements included 246 units of the newer da Vinci 5 model, showing continued adoption of advanced technology.

🌍 CEO Dave Rosa emphasized the company's commitment to helping customers deliver better patient outcomes and lower costs globally.

Bullish Signals
  • Revenue grew 19% year-over-year to $2.89 billion, demonstrating strong market demand for minimally invasive care solutions.
  • Instruments and accessories revenue increased by 18% to $1.73 billion, indicating robust recurring revenue streams from existing installed bases.
  • Ion procedure volume surged 36%, signaling successful adoption of the company's newer endoluminal system technology.
  • GAAP income from operations rose 31% to $972 million, reflecting improved operational efficiency and margin expansion.
  • Non-GAAP net income per diluted share increased to $2.80 from $2.19 in the prior year, showing strong underlying profitability.
  • The company placed 468 da Vinci systems in the quarter, including 254 under operating lease arrangements, expanding its recurring revenue model.
  • Cash and investments grew by $650 million to reach $8.63 billion, providing ample liquidity for future growth initiatives or share repurchases.
Full Analysis
Intuitive Surgical (ISRG) reported robust second-quarter 2026 financial results, driven by significant growth in both its core da Vinci and newer Ion robotic surgery platforms. Total revenue reached $2.89 billion, representing a 19% year-over-year increase from the prior year's $2.44 billion. This expansion was fueled by a 15% rise in da Vinci procedure volume and a substantial 36% surge in Ion procedure volume, alongside higher leasing revenue for its surgical systems. The company demonstrated strong operational performance with GAAP income from operations climbing to $972 million, up from $743 million in the previous year. Non-GAAP income from operations also saw a notable increase to $1.22 billion compared to $0.95 billion. Net income attributable to Intuitive Surgical rose to $818 million, or $2.29 per diluted share, reflecting improved profitability and cash generation capabilities despite higher share-based compensation expenses. Intuitive concluded the quarter with a healthy balance sheet, holding $8.63 billion in cash, cash equivalents, and investments, an increase of $650 million driven by operational cash flow. CEO Dave Rosa highlighted the strength of the company's portfolio, emphasizing the successful integration of digital solutions alongside its established robotic systems to deliver better patient outcomes and broader access to minimally invasive care globally.